News
Goldman Sachs Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $24
2 Apr 24
News, Price Target, Initiation, Analyst Ratings
Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $21 Price Target
12 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25
12 Mar 24
News, Price Target, Analyst Ratings
Citigroup Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $20
30 Jan 24
News, Price Target, Initiation, Analyst Ratings
Press releases
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
8 Apr 24
News, Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Apr 24
Press Releases
Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
11 Mar 24
Earnings, Press Releases
Olema Oncology Announces Publication of Data Highlighting Palazestrant's Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors
6 Mar 24
Health Care, Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Mar 24
Markets, Press Releases
Olema Oncology to Participate in Upcoming Investor Conferences
6 Feb 24
News, Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Feb 24
Markets, Press Releases